Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 20-Sep-24 4:15 PM View:  | Y-Mabs Therapeutics, Inc. (YMAB) | 19-Sep-24 | Option Exercise | 22,831 | $4.38 | $99,999.80 | 8% 286.38K to 309.21K | |
| 17-Sep-24 8:05 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 16-Sep-24 | Market Sale | 30,000 | $12.97 | $389,100.00 | (9%) 316.38K to 286.38K | (10%) |
| 17-Sep-24 8:05 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 13-Sep-24 | Market Sale | 65,000 | $13.47 | $875,550.00 | (17%) 381.38K to 316.38K | (6%) |
| 11-Jun-24 7:53 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 11-Jun-24 | Sale | 35,000 | $12.00 | $420,000.00 | (8%) 416.38K to 381.38K | |
| 11-Jun-24 7:53 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 10-Jun-24 | Sale | 35,000 | $12.03 | $421,050.00 | (8%) 451.38K to 416.38K | |
| 23-May-24 10:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 23-May-24 | Sale | 7,351 | $13.00 | $95,563.00 | (2%) 458.73K to 451.38K | |
| 23-May-24 10:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 21-May-24 | Sale | 25,000 | $12.00 | $300,000.00 | (5%) 483.73K to 458.73K | |
| 07-Mar-24 5:01 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 05-Mar-24 | Private Sale | 3,900 | $16.44 | $64,116.00 | (< 1%) 487.63K to 483.73K | |
| 22-Jan-24 5:52 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 18-Jan-24 | Grant | 22,100 | -- | -- | 5% 465.53K to 487.63K | |
| 26-Dec-23 4:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 21-Dec-23 | Option Exercise | 50,000 | $2.00 | $100,000.00 | 12% 415.53K to 465.53K | |
| 15-Dec-23 7:40 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 15-Dec-23 | Sale | 50,000 | $6.61 | $330,500.00 | (11%) 465.53K to 415.53K | |
| 15-Dec-23 7:40 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 14-Dec-23 | Sale | 50,000 | $6.83 | $341,500.00 | (10%) 515.53K to 465.53K | |
| 15-Dec-23 7:40 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 13-Dec-23 | Sale | 50,000 | $6.58 | $329,000.00 | (9%) 565.53K to 515.53K | |
| 22-Nov-23 5:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 21-Nov-23 | Sale | 75,000 | $5.31 | $397,988.00 | (12%) 640.53K to 565.53K | |
| 22-Nov-23 5:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 20-Nov-23 | Sale | 75,000 | $5.30 | $397,395.00 | (10%) 715.53K to 640.53K | |
| 19-Jan-23 4:42 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 17-Jan-23 | Grant | 40,500 | -- | -- | 6% 675.03K to 715.53K | |
| 09-Feb-22 6:59 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 09-Feb-22 | Sale | 64,276 | $6.96 | $447,117.00 | (9%) 739.31K to 675.03K | |
| 09-Feb-22 6:59 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 08-Feb-22 | Sale | 125,863 | $7.01 | $882,891.00 | (15%) 865.17K to 739.31K | |
| 09-Feb-22 6:59 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 07-Feb-22 | Sale | 91,031 | $7.59 | $691,180.00 | (10%) 956.2K to 865.17K | |
| 07-Feb-22 5:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 04-Feb-22 | Sale | 101,104 | $7.70 | $778,531.00 | (10%) 1.06M to 956.2K | |
| 07-Feb-22 5:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 03-Feb-22 | Sale | 35,060 | $7.90 | $277,027.00 | (3%) 1.09M to 1.06M | |
| 03-Feb-22 5:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 01-Feb-22 | Option Exercise | 8,000 | $2.00 | $16,000.00 | < 1% 1.09M to 1.1M | |
| 03-Feb-22 5:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 01-Feb-22 | Option Sale | 8,000 | $10.15 | $81,160.80 | (< 1%) 1.1M to 1.09M | |
| 26-Jan-22 5:09 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 24-Jan-22 | Sale | 88,055 | $10.63 | $936,412.00 | (7%) 1.18M to 1.09M | |
| 24-Jan-22 5:39 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 21-Jan-22 | Sale | 70,318 | $10.75 | $755,815.00 | (6%) 1.25M to 1.18M | |
| 24-Jan-22 5:39 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 20-Jan-22 | Sale | 112,767 | $11.33 | $1,277,290.00 | (8%) 1.36M to 1.25M | |
| 20-Jan-22 5:13 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 19-Jan-22 | Sale | 69,414 | $10.89 | $756,092.00 | (5%) 1.43M to 1.36M | |
| 20-Jan-22 5:13 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 18-Jan-22 | Option Exercise | 8,000 | $2.00 | $16,000.00 | < 1% 1.43M to 1.44M | |
| 20-Jan-22 5:13 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 18-Jan-22 | Option Sale | 8,000 | $11.54 | $92,314.40 | (< 1%) 1.44M to 1.43M | |
| 20-Jan-22 5:13 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 18-Jan-22 | Sale | 400 | $11.46 | $4,584.00 | (< 1%) 1.43M to 1.43M | |
| 16-Dec-21 6:35 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 14-Dec-21 | Gift | 60,000 | -- | -- | 2% 2.76M to 2.82M | |
| 16-Dec-21 6:35 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 14-Dec-21 | Gift | 60,000 | -- | -- | (2%) 2.82M to 2.76M | |
| 08-Dec-21 5:18 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 07-Dec-21 | Market Sale | 10,000 | $17.58 | $175,832.00 | (< 1%) 1.44M to 1.43M | 1% |
| 08-Dec-21 5:18 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 06-Dec-21 | Market Sale | 44,000 | $16.48 | $725,242.00 | (3%) 1.49M to 1.44M | (6%) |
| 01-Dec-21 5:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 30-Nov-21 | Market Sale | 21,170 | $17.08 | $361,545.00 | (1%) 1.51M to 1.49M | (< 1%) |
| 01-Dec-21 5:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 30-Nov-21 | Market Sale (Planned) | 4,000 | $16.98 | $67,912.40 | (< 1%) 1.49M to 1.49M | (< 1%) |
| 01-Dec-21 5:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 29-Nov-21 | Market Sale | 22,437 | $17.16 | $385,026.00 | (1%) 1.53M to 1.51M | < 1% |
| 26-Nov-21 5:33 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 23-Nov-21 | Option Exercise | 50,000 | $2.00 | $100,000.00 | 3% 1.53M to 1.58M | |
| 26-Nov-21 5:33 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 23-Nov-21 | Market Option Sale | 50,000 | $17.06 | $852,850.00 | (3%) 1.58M to 1.53M | |
| 18-Nov-21 5:18 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 16-Nov-21 | Market Sale (Planned) | 4,000 | $19.33 | $77,302.00 | (< 1%) 1.54M to 1.53M | 2% |
| 01-Nov-21 5:15 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 29-Oct-21 | Market Sale (Planned) | 4,000 | $24.82 | $99,260.80 | (< 1%) 1.54M to 1.54M | 1% |
| 19-Oct-21 5:17 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 15-Oct-21 | Market Sale (Planned) | 4,000 | $27.20 | $108,799.00 | (< 1%) 1.55M to 1.54M | 2% |
| 04-Oct-21 5:17 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 30-Sep-21 | Market Sale (Planned) | 4,000 | $28.26 | $113,054.00 | (< 1%) 1.55M to 1.55M | (4%) |
| 17-Aug-21 6:32 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 17-Aug-21 | Market Sale | 1,779 | $28.96 | $51,527.00 | (< 1%) 1.56M to 1.55M | (< 1%) |
| 17-Aug-21 6:32 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 16-Aug-21 | Market Sale | 22,111 | $29.33 | $648,527.00 | (1%) 1.58M to 1.56M | 1% |
| 17-Aug-21 6:32 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 16-Aug-21 | Market Sale (Planned) | 4,000 | $29.14 | $116,544.00 | (< 1%) 1.56M to 1.56M | < 1% |
| 17-Aug-21 6:32 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 13-Aug-21 | Market Sale | 1,110 | $31.01 | $34,425.60 | (< 1%) 1.58M to 1.58M | 7% |
| 05-Aug-21 10:00 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 03-Aug-21 | Market Sale (Planned) | 4,000 | $33.73 | $134,927.00 | (< 1%) 1.59M to 1.58M | 13% |
| 21-Jul-21 6:56 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 20-Jul-21 | Market Sale (Planned) | 4,000 | $32.47 | $129,875.00 | (< 1%) 1.59M to 1.59M | (< 1%) |
| 08-Jul-21 5:16 PM View: | Y-Mabs Therapeutics, Inc. (YMAB) | 07-Jul-21 | Market Sale (Planned) | 4,000 | $31.87 | $127,465.00 | (< 1%) 1.6M to 1.59M | (< 1%) |